David N Schwartz
Overview
Explore the profile of David N Schwartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rynkiewich K, Gole S, Won S, Schwartz D
Soc Sci Med
. 2023 Apr;
324:115834.
PMID: 37003024
Antimicrobial resistance (AMR) continues to present a challenge to international healthcare systems and structures of public health. The focus on optimizing antibiotic prescribing in human populations has challenged healthcare systems...
2.
Sarda V, Trick W, Zhang H, Schwartz D
Emerg Infect Dis
. 2021 Jul;
27(8):2127-2134.
PMID: 34287121
We performed a spatial and mixed ecologic study of community-onset Enterobacteriaceae isolates collected from a public healthcare system in Cook County, Illinois, USA. Individual-level data were collected from the electronic...
3.
Schwartz D, McConeghy K, Lyles R, Wu U, Glowacki R, Itokazu G, et al.
Infect Control Hosp Epidemiol
. 2017 Jun;
38(7):857-859.
PMID: 28571589
Clinician education and prospective audit and feedback interventions, deployed separately and concurrently, did not reduce antimicrobial use errors or rates compared to a control group of general medicine inpatients at...
4.
Morency-Potvin P, Schwartz D, Weinstein R
Clin Microbiol Rev
. 2016 Dec;
30(1):381-407.
PMID: 27974411
Antimicrobial stewardship is a bundle of integrated interventions employed to optimize the use of antimicrobials in health care settings. While infectious-disease-trained physicians, with clinical pharmacists, are considered the main leaders...
5.
6.
Hamilton K, Gerber J, Moehring R, Anderson D, Calderwood M, Han J, et al.
Clin Infect Dis
. 2015 Jan;
60(8):1252-8.
PMID: 25595748
Antimicrobial stewardship is pivotal to improving patient outcomes, reducing adverse events, decreasing healthcare costs, and preventing further emergence of antimicrobial resistance. In an era in which antimicrobial resistance is increasing,...
7.
Kassamali Z, Danziger L, Glowacki R, Schwartz D
Int J Infect Dis
. 2013 Mar;
17(8):e615-20.
PMID: 23474174
Objectives: Recommended doses of liposomal amphotericin B (L-AMB) range from 3 to 6 mg/kg/day, but 1mg/kg/day may be equally effective and a lower cost alternative for many indications. The objective...
8.
Teng C, Rezai K, Itokazu G, Xamplas R, Glowacki R, Rodvold K, et al.
Antimicrob Agents Chemother
. 2012 May;
56(6):3470-1.
PMID: 22581937
No abstract available.
9.
Agarwal R, Schwartz D
Clin Infect Dis
. 2011 Aug;
53(4):379-87.
PMID: 21810753
Can the use of serum procalcitonin levels safely reduce antimicrobial use in intensive care unit (ICU) patients? We performed a systematic literature review that identified 6 published randomized controlled trials...
10.
Schwartz D, Evans R, Camins B, Khan Y, Lloyd J, Shehab N, et al.
Infect Control Hosp Epidemiol
. 2011 Apr;
32(5):472-80.
PMID: 21515978
Objective: To outline methods for deriving and validating intensive care unit (ICU) antimicrobial utilization (AU) measures from computerized data and to describe programming problems that emerged. Design: Retrospective evaluation of...